Outcomes of Sentinel Lymph Node Biopsy Using Blue Dye Method for Early Breast Cancer – A Single-Institution Experience in the Philippines

References

• Global Cancer Observatory. Population fact sheet: Philippines. 2018 Available from:http://gco.iarc.fr/today/data/factsheets/populations/608-philippines-fact-sheets.pdf. Accessed 1129, 2019.
   Google Scholar
• KimH, ChoJ, KwonSY, KangSH. Biologic subtype is a more important prognostic factor than nodal involvement in patients with stages I and II breast carcinoma. Ann Surg Treat Res. 2016;90(1):1–9. doi:10.4174/astr.2016.90.1.126793686
   PubMed Web of Science ®Google Scholar
• GiulianoAE, KirganDM, GuentherJM, MortonDL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994;220(3):391–398. doi:10.1097/00000658-199409000-000158092905
   PubMed Web of Science ®Google Scholar
• MancaG, RubelloD, TardelliE, et al. Sentinel lymph node biopsy in breast cancer: indications, contraindications, and controversies. Clin Nucl Med. 2016;41(2):126–133. doi:10.1097/RLU.000000000000098526447368
   PubMed Web of Science ®Google Scholar
• KragDN, AndersonSJ, JulianTB, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised Phase 3 trial. Lancet Oncol. 2010;11(10):927–933. doi:10.1016/S1470-2045(10)70207-220863759
   PubMed Web of Science ®Google Scholar
• PeekMC, KovacsT, BakerR, HamedH, KothariA, DouekM. Is blue dye still required during sentinel lymph node biopsy for breast cancer?Ecancermedicalscience. 2016;10:674. doi:10.3332/ecancer.2016.67427729939
   PubMedGoogle Scholar
• LymanGH, SomerfieldMR, BossermanLD, PerkinsCL, WeaverDL, GiulianoAE. Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2017;35(5):561–564. doi:10.1200/JCO.2016.71.094727937089
   PubMed Web of Science ®Google Scholar
• SiguanS, BordeosL, Baking-FernandezS. A review of the accuracy of sentinel lymph node biopsy by comparing frozen section with final paraffin block H&E staining, and correlation with the final axillary lymph node dissection results. PJSS. 2016;71(2):41–45.
   Google Scholar
• Tolentino-MolinaM, Datay-LimS, AlcazarenE. Intraoperative frozen section assessment of sentinel lymph nodes in breast cancer: six-year experience in a Tertiary Hospital. PJP. 2016;1(1). doi:10.21141/PJP.2016.006
   Google Scholar
• SimbulanMHJr, BelmonteAH, PaulinoAPJr, NiloC, PSGS Breast Study Group. Evidence-based clinical practice guidelines for early breast cancer. PJSS. 2013;68(2):41–74.
   Google Scholar
• CardosoF, KyriakidesS, OhnoS, et al. Early breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2019;30(8):1194–1220. doi:10.1093/annonc/mdz17331161190
   PubMed Web of Science ®Google Scholar
• CorradiniS, ReitzD, PazosM, et al. Mastectomy or breast-conserving therapy for early breast cancer in real-life clinical practice: outcome comparison of 7565 cases. Cancers (Basel). 2019;11(2):160. doi:10.3390/cancers11020160
   Web of Science ®Google Scholar
• ChurillaTM, DonnellyPE, LeathermanER, AdonizioCS, PetersCA. Total mastectomy or breast conservation therapy? How radiation oncologist accessibility determines treatment choice and quality: a SEER data-base analysis. Breast J. 2015;21(5):473–480. doi:10.1111/tbj.1244926133235
   PubMed Web of Science ®Google Scholar
• Van MaarenMC, De MunckL, De BockGH, et al. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study. Lancet Oncol. 2016;17(8):1158–1170. doi:10.1016/S1470-2045(16)30067-527344114
   PubMed Web of Science ®Google Scholar
• CubaschH, JoffeM, RuffP, et al. Breast conservation surgery versus total mastectomy among women with localized breast cancer in Soweto, South Africa. PLoS One. 2017;12(8):e0182125. doi:10.1371/journal.pone.018212528797046
   PubMed Web of Science ®Google Scholar
• WongWJ, MosiunJA, HidayatiZ, et al. Low Breast Conserving Surgery (BCS) rates in public hospitals in Malaysia: the effect of stage and ethnicity. Breast. 2019;46:136–143. doi:10.1016/j.breast.2019.05.01631176055
   PubMed Web of Science ®Google Scholar
• KaklamanosIG, BirbasK, SyrigosK, BonatsosVG, BonatsosG. Prospective comparison of peritumoral and subareolar injection of blue dye alone, for identification of sentinel lymph nodes in patients with early stage breast cancer. J Surg Oncol. 2011;104(1):37–40. doi:10.1002/jso.2189721360537
   PubMed Web of Science ®Google Scholar
• ReyesF, NoelckM, ValentinoC, Grasso-lebeauL, LangJ. Complications of methylene blue dye in breast surgery: case reports and review of the literature. J Cancer. 2010;2:20–25. doi:10.7150/jca.2.2021197261
   PubMed Web of Science ®Google Scholar
• SalhabM, Al SarakbiW, MokbelK. Skin and fat necrosis of the breast following methylene blue dye injection for sentinel node biopsy in a patient with breast cancer. Int Semin Surg Oncol. 2005;2(1):26. doi:10.1186/1477-7800-2-2616313674
   PubMedGoogle Scholar
• StradlingB, AranhaG, GabramS. Adverse skin lesions after methylene blue injections for sentinel lymph node localization. Am J Surg. 2002;184(4):350–352. doi:10.1016/S0002-9610(02)00945-512383900
   PubMed Web of Science ®Google Scholar
• BrenetO, LalourceyL, QueinnecM, et al. Hypersensitivity reactions to patent blue V in breast cancer surgery: a prospective multicentre study. Acta Anaesthesiol Scand. 2013;57(1):106–111. doi:10.1111/aas.1200323216362
   PubMed Web of Science ®Google Scholar
• BarthelmesL, GoyalA, NewcombeRG, McneillF, ManselRE. Adverse reactions to patent blue V dye - The NEW START and ALMANAC experience. Eur J Surg Oncol. 2010;36(4):399–403. doi:10.1016/j.ejso.2009.10.00719939618
   PubMed Web of Science ®Google Scholar
• GropperAB, CalvilloKZ, DominiciL, et al. Sentinel lymph node biopsy in pregnant women with breast cancer. Ann Surg Oncol. 2014;21(8):2506–2511. doi:10.1245/s10434-014-3718-224756813
   PubMed Web of Science ®Google Scholar
• National Comprehensive Cancer Network. Breast cancer (Version 2.2020). Available from:https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf. Accessed 208, 2020.
   Google Scholar
• AlhussiniMA, AwadAT, AshourMH, AbdelateefA, FayedH. Breast cancer sentinel node detection: an alternative solution for centers lacking nuclear technology. Breast Care (Basel). 2016;11(4):265–268. doi:10.1159/00044840927721714
   PubMed Web of Science ®Google Scholar
• SeenuV, SuhaniS, SrivastavaA, ParshadR, MathurS, KumarR. Optimization of sentinel lymph node identification techniques in the Indian setting: a randomized clinical trial. Indian J Cancer. 2019;56(2):114–118. doi:10.4103/ijc.IJC_163_1831062728
   PubMed Web of Science ®Google Scholar
• MotomuraK, InajiH, KomoikeY, et al. Combination technique is superior to dye alone in identification of the sentinel node in breast cancer patients. J Surg Oncol. 2001;76(2):95–99. doi:10.1002/(ISSN)1096-909811223834
   PubMed Web of Science ®Google Scholar
• RadovanovicZ, GolubovicA, PlzakA, StojiljkovicB, RadovanovicD. Blue dye versus combined blue dye-radioactive tracer technique in detection of sentinel lymph node in breast cancer. Eur J Surg Oncol. 2004;30(9):913–917. doi:10.1016/j.ejso.2004.08.00315498633
   PubMed Web of Science ®Google Scholar
• LiJ, ChenX, QiM, LiY, MetzeK. Sentinel lymph node biopsy mapped with methylene blue dye alone in patients with breast cancer: a systematic review and meta-analysis. PLoS One. 2018;13(9):e0204364. doi:10.1371/journal.pone.020436430235340
   PubMed Web of Science ®Google Scholar
• PesekS, AshikagaT, KragLE, KragD. The false-negative rate of sentinel node biopsy in patients with breast cancer: a meta-analysis. World J Surg. 2012;36(9):2239–2251. doi:10.1007/s00268-012-1623-z22569745
   PubMed Web of Science ®Google Scholar
• GoyalA, NewcombeRG, ChhabraA, ManselRE. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer–results of the ALMANAC validation phase. Breast Cancer Res Treat. 2006;99(2):203–208. doi:10.1007/s10549-006-9192-116541308
   PubMed Web of Science ®Google Scholar
• The American Society of Breast of Surgeons. Performance and practice guidelines for sentinel lymph node biopsy in breast cancer patients. 2014 Available from:https://www.breastsurgeons.org/docs/statements/Performance-and-Practice-Guidelines-for-Sentinel-Lymph-Node-Biopsy-in-Breast-Cancer-Patients.pdf. Accessed 1210, 2020.
   Google Scholar
• HeK, ChiC, KouD, et al. Comparison between the indocyanine green fluorescence and blue dye methods for sentinel lymph node biopsy using novel fluorescence image-guided resection equipment in different types of hospitals. Transl Res. 2016;178:74–80. doi:10.1016/j.trsl.2016.07.01027497181
   PubMed Web of Science ®Google Scholar
• GuoJ, YangH, WangS, et al. Comparison of sentinel lymph node biopsy guided by indocyanine green, blue dye, and their combination in breast cancer patients: a prospective cohort study. World J Surg Oncol. 2017;15(1):196. doi:10.1186/s12957-017-1264-729096643
   PubMed Web of Science ®Google Scholar
• TarunoK, KuritaT, KuwahataA, et al. Multicenter clinical trial on sentinel lymph node biopsy using superparamagnetic iron oxide nanoparticles and a novel handheld magnetic probe. J Surg Oncol. 2019;120(8):1391–1396. doi:10.1002/jso.v120.831667855
   PubMed Web of Science ®Google Scholar
• ManV, WongTT, CoM, SuenD, KwongA. Sentinel lymph node biopsy in early breast cancer: magnetic tracer as the only localizing agent. World J Surg. 2019;43(8):1991–1996. doi:10.1007/s00268-019-04977-130888473
   PubMed Web of Science ®Google Scholar
• Nielsen MoodyA, BullJ, CulpanAM, et al. Preoperative sentinel lymph node identification, biopsy and localisation using contrast enhanced ultrasound (CEUS) in patients with breast cancer: a systematic review and meta-analysis. Clin Radiol. 2017;72(11):959–971. doi:10.1016/j.crad.2017.06.12128774472
   PubMed Web of Science ®Google Scholar
• ChagparAB, ScogginsCR, MartinRC, et al. Are 3 sentinel nodes sufficient?Arch Surg. 2007;142(5):456–459. doi:10.1001/archsurg.142.5.45617515487
   PubMedGoogle Scholar
• YiM, Meric-bernstamF, RossMI, et al. How many sentinel lymph nodes are enough during sentinel lymph node dissection for breast cancer?Cancer. 2008;113(1):30–37. doi:10.1002/cncr.2351418457326
   PubMed Web of Science ®Google Scholar
• GiulianoAE, BallmanKV, MccallL, et al. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial. JAMA. 2017;318(10):918–926. doi:10.1001/jama.2017.1147028898379
   PubMed Web of Science ®Google Scholar
• GalimbertiV, ColeBF, VialeG, et al. Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial. Lancet Oncol. 2018;19(10):1385–1393. doi:10.1016/S1470-2045(18)30380-230196031
   PubMed Web of Science ®Google Scholar
• HashemiE, KavianiA, NajafiM, EbrahimiM, HooshmandH, MontazeriA. Seroma formation after surgery for breast cancer. World J Surg Oncol. 2004;2(1):44. doi:10.1186/1477-7819-2-4415588301
   PubMedGoogle Scholar
• EbnerF, FriedlTWP, De GregorioA, et al. Seroma in breast surgery: all the surgeons fault?Arch Gynecol Obstet. 2018;298(5):951–959. doi:10.1007/s00404-018-4880-830196358
   PubMed Web of Science ®Google Scholar
• GiulianoAE, HuntKK, BallmanKV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305(6):569–575. doi:10.1001/jama.2011.9021304082
   PubMed Web of Science ®Google Scholar
• LangerI, GullerU, BerclazG, et al. Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients. Ann Surg. 2007;245(3):452–461. doi:10.1097/01.sla.0000245472.47748.ec17435553
   PubMed Web of Science ®Google Scholar
• MclaughlinSA, WrightMJ, MorrisKT, et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol. 2008;26(32):5213–5219. doi:10.1200/JCO.2008.16.372518838709
   PubMed Web of Science ®Google Scholar
• MorrowM, GolshanM. Chapter 33: mastectomy In: HarrisJR, LippmanME, MorrowM, OsborneCK, editors. Diseases of the Breast. 5th ed. Philadelphia: Wolters Kluwer Health; 2014:504–509.
   Google Scholar
• VeronesiU, CascinelliN, MarianiL, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347(16):1227–1232. doi:10.1056/NEJMoa02098912393819
   PubMed Web of Science ®Google Scholar
• VeronesiU, LuiniA, Del VecchioM, et al. Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. N Engl J Med. 1993;328(22):1587–1591. doi:10.1056/NEJM1993060332822028387637
   PubMed Web of Science ®Google Scholar
• VeronesiU, MarubiniE, MarianiL, et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol. 2001;12(7):997–1003. doi:10.1023/A:101113632694311521809
   PubMed Web of Science ®Google Scholar
• FisherB, AndersonS, BryantJ, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347(16):1233–1241. doi:10.1056/NEJMoa02215212393820
   PubMed Web of Science ®Google Scholar
• De BonifaceJ, FrisellJ, BergkvistL, AnderssonY. Ten-year report on axillary recurrence after negative sentinel node biopsy for breast cancer from the Swedish Multicentre Cohort Study. Br J Surg. 2017;104(3):238–247. doi:10.1002/bjs.1041128052310
   PubMed Web of Science ®Google Scholar
• InoueT, NishiT, NakanoY, et al. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer. Breast Cancer. 2016;23(2):295–300. doi:10.1007/s12282-014-0573-825348937
   PubMed Web of Science ®Google Scholar